Price alone won't push weight-loss, diabetes drug semaglutide sales: Doctors

Leading drugmakers including Sun Pharmaceuticals, Dr Reddy’s Laboratories, Zydus Lifesciences, Natco Pharma, Eris Lifesciences, USV, Glenmark, and Torrent were among the first to roll out generic semaglutide on the first day of patent expiry of Novo Nordisk’s innovator molecule on Saturday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/my3X8YP
via IFTTT